Schedule 4 Monitoring for indicative dose and analytical performance characteristics England and Wales 1Monitoring for compliance with the ID 2Screening for certain radionuclides or for an individual radionuclide 3Screening strategies for gross alpha activity and gross beta activity 4Calculation of the ID ← Schedule 3 Schedule 4 Paragraph 1 →